
Kanbalin M 750mcg/75mg Tablet
Marketer
Fortune Life Sciences Private Limited
Salt Composition
Methylcobalamin (750mcg) + Pregabalin (75mg)
Overview Kanbalin M 750mcg/75mg Tablet
Neuropathic pain is treated with the prescription medication, Kanbalin M 750mcg/75mg Tablet. Its mechanism involves modulating nerve cell calcium channel activity to reduce pain, promoting nerve fiber protection and repair of damaged cells. Administered orally, with or without food, ideally at bedtime and consistently daily for therapeutic blood levels, this medication should be taken as directed. Due to its potential for dependence, adherence to the prescribed dosage and duration is crucial. Missed doses should be taken promptly upon recollection; the entire treatment course must be completed regardless of symptom improvement. Abrupt cessation requires prior physician consultation. Common, typically mild and transient, side effects include nasal congestion, increased hunger, elevated mood, trembling, visual blurring, dry mouth, vertigo, and somnolence. Avoid activities demanding concentration until the medication's effects are known. Weight gain is possible; regular exercise and a healthy diet are recommended to mitigate this. Report any unusual mood or behavioral shifts, new or worsening depression, or suicidal ideation to your doctor immediately. Full disclosure of all concurrent medications is essential as interactions may affect Kanbalin M's efficacy or action. Inform your physician of pregnancy, pregnancy planning, or breastfeeding.
Uses of Kanbalin M 750mcg/75mg Tablet
Managing neuropathic pain
Major Benefits of Kanbalin M 750mcg/75mg Tablet:
Administer this medication precisely as prescribed by your physician, adhering to both the dosage and treatment duration. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Kanbalin M 750mcg/75mg Tablets can be consumed with or without food, though consistent timing is recommended.
Common Side effects of Kanbalin M 750mcg/75mg Tablet:
- Sleepiness
- Dizziness
- Nasopharyngitis (inflammation of the throat and nasal passages)
- Increased appetite
- Blurred vision
- Constipation
- Muscle cramp
- Edema (swelling)
- Erectile dysfunction
- Weight gain
- Balance disorder (loss of balance)
- Lethargy
- Vertigo
- Vomiting
- Headache
- Confusion
- Disorientation
- Abnormality of voluntary movements
How to use Kanbalin M 750mcg/75mg Tablet:
Administer this medication precisely as prescribed by your physician, adhering to the recommended dosage and treatment schedule. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Kanbalin M 750mcg/75mg Tablets can be consumed with or without food, though consistent timing is preferable.
How Kanbalin M 750mcg/75mg Tablet works:
Kanbalin M 750mcg/75mg tablets combine methylcobalamin and pregabalin to alleviate neuropathic pain. Methylcobalamin, a vitamin B12 variant, supports myelin production, shielding nerve fibers and aiding the repair of damaged nerve cells. Pregabalin, acting as an alpha-2-delta ligand, reduces pain signals by modulating nerve cell calcium channel activity. This dual action provides effective relief from nerve-related pain.
SAFETY ADVICE
AlcoholUNSAFE
Concurrent use of Kanbalin M 750mcg/75mg tablets and alcohol may result in pronounced somnolence.
PregnancyCONSULT YOUR DOCTOR
The use of Kanbalin M 750mcg/75mg tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the potential advantages against any possible risks prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
The use of Kanbalin M 750mcg/75mg Tablet while breastfeeding is likely inadvisable. Scant evidence from human studies indicates potential transfer of the medication into breast milk, posing a possible risk to the infant.
DrivingUNSAFE
Taking Kanbalin M 750mcg/75mg tablets might reduce alertness, impair vision, or cause drowsiness and dizziness. Refrain from driving if you experience these effects.
KidneyCAUTION
Patients with kidney impairment should use Kanbalin M 750mcg/75mg Tablets cautiously, potentially requiring dosage modification. Physician consultation is advised.
LiverSAFE IF PRESCRIBED
Use of Kanbalin M 750mcg/75mg Tablet in patients with liver disease appears to pose minimal risk. Preliminary evidence indicates dose modification may be unnecessary, however, physician consultation is advised.
What if you forget to take Kanbalin M 750mcg/75mg Tablet :
Should you forget a Kanbalin M 750mcg/75mg Tablet dose, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Kanbalin M 750mcg/75mg Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Neuroscience Central Nervous System |
